Prostate Cancer Treatment Market by Drug Type (Biological Therapy, Chemotherapy, Hormone Therapy, Others), Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies), Region Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027

  • Publish Date: Sep, 2020
  • Report ID: 418910
  • Category: Healthcare
  • Pages: 225
$4700

The prostate cancer treatment market is expected to grow from USD 7.22 billion in 2019 to USD 10.67 billion by 2027, at a CAGR of 5% during the forecast period 2020-2027.

Prostate cancer is a form of cancer where abnormal cells grow and invade in the prostate gland's controlled manner. It is one of the most common cancer cases after skin cancer and prevalent in geriatric men over the age of 50. Prostate cancer starts when cells in the prostate gland begins to grow out of control. Prostate cancer treatment is dependent on the stage of cancer. Some of the prostate cancer grows slowly, whereas others may require monitoring. The various diagnostics and therapeutic products used in the treatment and management of prostate cancer are prostatic adenocarcinoma, small cell carcinoma, and benign prostatic hyperplasia, and various others. 

The factors driving the market are the adoption of innovative technologies in screening and diagnostic tests, incorporation of multiparametric MRI, an increase in the prevalence of prostate cancer, and the availability of new prostate cancer treatments. Poor demand for prostate cancer treatment drugs in underdeveloped countries, prolonged treatment durations, and high costs associated with tissue biopsy in advanced cancer stage will hamper the market growth. Improved R & D investment by drug innovators will provide market growth opportunities.

This study delivers a comprehensive analysis of drug type, distribution channel, and region. The drug type segment includes biological therapy, chemotherapy, hormone therapy, and others. Hormone therapy holds the largest market share, owing to the increased prevalence of prostate cancer, rising demand for hormone therapy, rise in the geriatric population, availability of generic drugs, and rise in public awareness towards prostate cancer treatment. Based on the distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment holds the largest market share, owing to the rise in the number of hospitalizes prostate cancer patients, the convenience offered by hospital pharmacies, and the strong presence of hospital pharmacies worldwide.

The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia-Pacific region dominated the market, owing to the rise in the adoption of prostate cancer treatment products, increasing awareness about prostate cancer, and improvements in healthcare infrastructure. North America region is expected to witness significant growth due to the rising prevalence and high mortality rates of prostate cancer. In the region, the U.S holds the largest share, due to the large investments in R&D for the development of newer immunotherapy and drug therapies for the treatment of prostate cancer. 

Some of the notable players in the market are AstraZeneca plc, Ipsen Pharms, AstellasPharma Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson, Takeda Pharmaceutical Company Ltd., Ferring Pharmaceuticals Inc., and Hoffmann-La Roche AG. In June 2019, IpsenPharma and Debiopharm extended their partnership for the next 15 years for Decapeptly, used for the treatment of gynecological, urcological, and pediatric conditions.

Prostate Cancer Treatment Market Analysis and Forecast, Drug Type

  • Biological Therapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Prostate Cancer Treatment Market Analysis and Forecast, Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

Prostate Cancer Treatment Market Analysis and Forecast, Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherland
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest Of APAC
  • South America
    • Brazil
    • Argentina
    • Peru
    • Colombia
    • Rest Of South America
  • Middle East And Africa
    •  UAE
    •  Saudi Arabia
    •  Egypt
    •  Nigeria
    •  South Africa
    • Rest Of MEA

Report Description:

  • The base year for the study has been considered 2019, historic year 2017 and 2018, the forecast period considered is from 2020 to 2027.
  • The study delivers a comprehensive analysis of global market for all segments and region
  • The report offers in-depth analysis of driving factors, opportunities and restraints for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2020 to 2027.
  • Porter’s Five Forces model is used in order to recognize the competitive scenario in the market. This report incorporates the industry analysis which is focused on providing an extensive view of the market.
  • The study also includes attractiveness analysis of all segments and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunist for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Drug Type
          4.3.2. Market Attractiveness Analysis By Distribution Channel
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends
5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increase in the prevalence of prostate cancer
          5.2.2. Availability of new prostate cancer treatments
    5.3. Restrains
          5.3.1. Prolonged treatment durations
    5.4. Opportunities
          5.4.1. Improved R&D investment by drug innovators
6. Global Prostate Cancer Treatment Market Analysis and Forecast, By Drug Type
    6.1. Segment Overview
    6.2. Biological Therapy
    6.3. Chemotherapy
    6.4. Hormone Therapy
    6.5. Others
7. Global Prostate Cancer Treatment Market Analysis and Forecast, By Distribution Channel
    7.1. Segment Overview
    7.2. Hospital Pharmacies
    7.3. Drug Stores & Retail Pharmacies
    7.4. Online Pharmacies
8. Global Prostate Cancer Treatment Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa
9. Global Prostate Cancer Treatment Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Prostate Cancer Treatment Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Distribution Channel Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions
10. Company Profiles
    10.1. AstraZeneca plc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Ipsen Pharms
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. AstellasPharma Inc.
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Bristol-Myers Squibb Company
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Bayer AG
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. GlaxoSmithKline Plc.
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Johnson & Johnson
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Takeda Pharmaceutical Company Ltd.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Ferring Pharmaceuticals Inc
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Hoffmann-La Roche AG
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis

List of Table

1. Global Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

2. Global Biological Therapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

3. GlobalChemotherapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

4. GlobalHormone Therapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

5. GlobalOthers, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

6. Global Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

7. Global Hospital Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

8. Global Drug Stores & Retail Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

9. Global Online Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)

10. North America Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

11. North America Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

12. U.S. Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

13. U.S. Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

14. Canada Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

15. CanadaProstate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

16. Mexico Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

17. Mexico Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

18. Europe Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

19. Europe Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

20. Germany Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

21. Germany Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

22. France Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

23. France Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

24. U.K. Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

25. U.K. Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

26. Italy Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

27. Italy Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

28. Spain Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

29. Spain Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

30. Asia Pacific Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

31. Asia Pacific Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

32. Japan Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

33. Japan Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

34. China Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

35. China Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

36. India Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

37. India Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

38. South America Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

39. South America Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

40. Brazil Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

41. Brazil Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

42. Middle East and Africa Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

43. Middle East and Africa Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

44. UAE Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

45. UAE Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

46. South Africa Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)

47. South Africa Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)

List of Figures 

1. Global Prostate Cancer Treatment Market Segmentation

2. Global Prostate Cancer Treatment Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Prostate Cancer Treatment Market Attractiveness Analysis By Drug Type

9. Global Prostate Cancer Treatment Market Attractiveness Analysis By Distribution Channel

10. Global Prostate Cancer Treatment Market Attractiveness Analysis By Region

11. Global Prostate Cancer Treatment Market: Dynamics

12. Global Prostate Cancer Treatment Market Share by Drug Type(2020 & 2027)

13. Global Prostate Cancer Treatment Market Share by Distribution Channel (2020 & 2027)

14. Global Prostate Cancer Treatment Market Share by Regions (2020 & 2027)

15. Global Prostate Cancer Treatment Market Share by Company (2019)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


+1

Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.